Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study ofJBZ-001
Category Press Releases
Multi-institutional team awarded NCI grant to open novel AML trial
Jabez Biosciences, Inc. Announced Phase 1 Clinical Trial of JBZ-001 at AACR 2025
Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma
Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001
